The identification of six risk genes for ovarian cancer platinum response based on global network algorithm and verification analysis
Author:
Affiliation:
1. Department of Gynecology Harbin Medical University Cancer Hospital Harbin China
2. College of Bioinformatics Science and Technology Harbin Medical University Harbin China
Publisher
Wiley
Subject
Cell Biology,Molecular Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.15567
Reference79 articles.
1. Evaluation of New Platinum-Based Treatment Regimens in Advanced-Stage Ovarian Cancer: A Phase III Trial of the Gynecologic Cancer InterGroup
2. Recurrent Epithelial Ovarian Carcinoma: A Randomized Phase III Study of Pegylated Liposomal Doxorubicin Versus Topotecan
3. Development of Nanoscale Approaches for Ovarian Cancer Therapeutics and Diagnostics
4. The biology of ovarian cancer: new opportunities for translation
5. Replication Protein A Availability during DNA Replication Stress Is a Major Determinant of Cisplatin Resistance in Ovarian Cancer Cells
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Prospects of POLD1 in Human Cancers: A Review;Cancers;2023-03-22
2. Identification of Biomarkers for Cervical Cancer Radiotherapy Resistance Based on RNA Sequencing Data;Frontiers in Cell and Developmental Biology;2021-08-03
3. BECN1 and BRCA1 Deficiency Sensitizes Ovarian Cancer to Platinum Therapy and Confers Better Prognosis;Biomedicines;2021-02-18
4. What is new about ovarian malignancies?;Współczesna Onkologia;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3